•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.PL Gold Mine Restart Update High Grade Gold Results, Resource Expansion Potential and Operational Readiness Update
Why This 15.3%-Paying CEF Is Making Big Changes
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
MCI: Easing Share Price Leads To Premium Decline; This Could Be The Reason
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
MCI: Interest Rate Hikes Can Negatively Impact Performance
How To Invest For Secure Retirement With Big Dividends, 5.7% Yield
Allegiant Adds Eight New Nonstop Routes, Expanding Service to Florida
Barings Corporate Investors Reports Preliminary First Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share
$5,000 Monthly Passive Income For Financial Freedom
Barings Corporate Investors (NYSE:MCI) versus ONEX (OTCMKTS:ONEXF) Financial Review
Barings Corporate Investors Reports Preliminary Fourth Quarter 2025 Results
My Income Portfolio - A Random Walk
Barings Corporate Investors (NYSE:MCI) versus Great Elm Capital Group (NASDAQ:GECC) Critical Survey
Reviewing Great Elm Capital Group (NASDAQ:GECC) & Barings Corporate Investors (NYSE:MCI)
MCI: Distributions May Get Reduced If Earnings Decline
My Income Portfolio's Year-End Review
Barings Corporate Investors Announces Quarterly Cash Dividend of $0.40 Per Share
Barings Corporate Investors Reports Preliminary Third Quarter 2025 Results